Table 5. Adverse events.

	Included patients N = 258
	Eczema N = 87	Psoriasis N = 125	Other dermatoses N = 45	Total N = 258*
Erythema N (%)	3 (3.5%)	6 (4.8%)	1 (2.2%)	10 (3.9%)
Related to treatment N	3	6	1	10
Serious effect N	0	0	0	0
Itching N (%)	2 (2.3%)	6 (4.8%)	0 (0%)	8 (3.1%)
Related to treatment N	2	6	0	8
Serious effect N	0	0	–	0
Skin thinning N (%)	0 (0%)	1 (0.9)	1 (2.2%)	2 (0.8%)
Related to treatment N	–	1	1	2
Serious effect N	–	0	0	0
Other annoying effect N (%)	1 (1.6%)	4 (3.2%)	1 (2.2%)	6 (2.3%)
Related to treatment N	0	0	1	1
Serious effect N	0	0	0	0

*For 1 patient, the CRF has not been returned.